Skip to main content
SpringerLink
Log in

Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Purpose

The main treatment for resectable rectal cancer T2–T4 N0–N2 M0 is surgery. The benefit of preoperative or postoperative radiation therapy can be analyzed in terms of improvement of local control, sphincter preservation, and survival weighted against increased toxicity.

Methods

Only randomized trials can provide strong evidence of a positive cost-benefit ratio of such combined approach. The most recent trials were reviewed.

Results

Three randomized trials, including the latest German CAO-ARO trial, have demonstrated the superiority of preoperative radiotherapy with or without chemotherapy (vs. postoperative) in terms of local control and toxicity. The Ducth TME trial showed that even with modern standard surgery, preoperative radiotherapy improved local control. Preoperative irradiation using a high dose in a small volume and a long interval before surgery may improve sphincter preservation (Lyon trials). Concurrent chemoradiation (FFCD 9203, EORTC 22921, did not significantly improve sphincter preservation or survival but significantly reduced the local recurrence rate.

Conclusions

In 2005 examination of randomized trials provides evidence for the benefit of preoperative chemoradiation in improving local control and probably sphincter preservation in rectal cancer. Randomized trials should be designed to further demonstrate improved sphincter preservation and to increase survival using adjuvant medical treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. RJ Heald BJ Moran RD Ryall R Sexton JK MacFarlane (1998) ArticleTitleRectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997 Arch Surg 133 894–9 Occurrence Handle1:STN:280:DyaK1cznsFOrsQ%3D%3D Occurrence Handle9711965

    CAS  PubMed  Google Scholar 

  2. InstitutionalAuthorNameAnonymous (1996) ArticleTitleRandomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party Lancet 348 1610–1614

    Google Scholar 

  3. MJ O'Connell JA Martenson HS Wieand et al. (1994) ArticleTitleImproving adjuvant therapy for rectal cancer by combining protracted-infusion Fluorouracil with radiation therapy after curative surgery N Engl J Med 331 502–507 Occurrence Handle10.1056/NEJM199408253310803 Occurrence Handle8041415

    Article  PubMed  Google Scholar 

  4. InstitutionalAuthorNameColorectal Cancer Collaborative Group (2001) ArticleTitleAdjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomized trials Lancet 358 1291–1304

    Google Scholar 

  5. InstitutionalAuthorNameAnonymous (1997) ArticleTitleImproved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 336 980–987

    Google Scholar 

  6. C Camma M Giunta F Fiorica L Pagliaro A Craxi M Cottone (2000) ArticleTitlePreoperative radiotherapy for resectable rectal cancer: a meta-analysis JAMA 284 1008–1015 Occurrence Handle10.1001/jama.284.8.1008 Occurrence Handle1:STN:280:DC%2BD3cvitFKjtQ%3D%3D Occurrence Handle10944647

    Article  CAS  PubMed  Google Scholar 

  7. GJ Frykholm B Glimelius L Pahlman (1993) ArticleTitlePreoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects Dis Colon Rectum 36 564–572 Occurrence Handle10.1007/BF02049863 Occurrence Handle1:STN:280:ByyB2s3mtFM%3D Occurrence Handle8500374

    Article  CAS  PubMed  Google Scholar 

  8. L Pahlman B Glimelius (1990) ArticleTitlePre or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial Ann Surg 211 187–195 Occurrence Handle1:STN:280:By%2BC2cnltFY%3D Occurrence Handle2405793

    CAS  PubMed  Google Scholar 

  9. DM Hyams EP Mamounas N Petrelli et al. (1997) ArticleTitleA clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03 Dis Colon Rectum 40 131–139 Occurrence Handle10.1007/BF02054976 Occurrence Handle1:STN:280:ByiB3s%2Fhs1M%3D Occurrence Handle9075745

    Article  CAS  PubMed  Google Scholar 

  10. R Sauer H Becker W Hohenberger et al. (2004) ArticleTitlePreoperative versus postoperative radiochemotherapy for rectal cancer N Engl J Med 351 1731–1740 Occurrence Handle10.1056/NEJMoa040694 Occurrence Handle1:CAS:528:DC%2BD2cXovFSksbo%3D Occurrence Handle15496622

    Article  CAS  PubMed  Google Scholar 

  11. E Kapiteijn CA Marijnen ID Nagtegaal et al. (2001) ArticleTitlePreoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638–646 Occurrence Handle10.1056/NEJMoa010580 Occurrence Handle1:STN:280:DC%2BD3Mvps1ektw%3D%3D Occurrence Handle11547717

    Article  CAS  PubMed  Google Scholar 

  12. Marijnen CA, Peeters KC, Putter H, et al. Cooperative investigators of the TME trial. Long term results, toxicity and quality of life in the TME trial. Presented at the ESTRO Meeting, Amsterdam, October 24–28, 2004, abstract 283.

  13. CA Marijnen ID Nagtegaal E Klein Kranenbarg et al. (2001) ArticleTitleNo downstaging after short-term preoperative radiotherapy in rectal cancer patients J Clin Oncol 19 1976–1984 Occurrence Handle1:STN:280:DC%2BD3M3js1yltA%3D%3D Occurrence Handle11283130

    CAS  PubMed  Google Scholar 

  14. M Dahlberg B Glimelius W Graf L Pahlman (1998) ArticleTitlePreoperative irradiation affects functional results after surgery for rectal cancer Dis Colon Rectum 41 543–549 Occurrence Handle10.1007/BF02235256 Occurrence Handle1:STN:280:DyaK1c3lsVSltA%3D%3D Occurrence Handle9593234

    Article  CAS  PubMed  Google Scholar 

  15. HG Moore E Riedel BD Minsky et al. (2003) ArticleTitleAdequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy Ann Surg Oncol 10 80–85 Occurrence Handle10.1245/ASO.2003.04.010 Occurrence Handle12513965

    Article  PubMed  Google Scholar 

  16. Y Francois CJ Nemoz J Baulieux et al. (1999) ArticleTitleInfluence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial J Clin Oncol 17 2396 Occurrence Handle1:STN:280:DC%2BD3c%2FjtVSgsw%3D%3D Occurrence Handle10561302

    CAS  PubMed  Google Scholar 

  17. A Pollack GK Zagars G Starkschall et al. (2002) ArticleTitleProstate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 1097–1105 Occurrence Handle12128107

    PubMed  Google Scholar 

  18. P Romestaing Y Lehingue C Carrie et al. (1997) ArticleTitleRole of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized trial in Lyon, France JClin Oncol 15 963–968 Occurrence Handle1:STN:280:ByiB3MzosVE%3D

    CAS  Google Scholar 

  19. JP Gerard O Chapet A Ramaioli P Romestaing (2002) ArticleTitleLong-term control of T2–T3 rectal adenocarcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 54 142–149 Occurrence Handle12182984

    PubMed  Google Scholar 

  20. JP Gerard O Chapet C Nemoz et al. (2004) ArticleTitleImproved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the LYON R96-02 randomized trial J Clin Oncol 22 2404–2409 Occurrence Handle10.1200/JCO.2004.08.170 Occurrence Handle15197202

    Article  PubMed  Google Scholar 

  21. B Minsky A Cohen W Enker et al. (1994) ArticleTitlePreoperative 5 fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer Cancer 73 273–280 Occurrence Handle1:STN:280:ByuC38zit1c%3D Occurrence Handle8293388

    CAS  PubMed  Google Scholar 

  22. JF Bosset V Magnin P Maingon et al. (2000) ArticleTitlePreoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial Int J Radiat Oncol Biol Phys 46 323–327 Occurrence Handle10.1016/S0360-3016(99)00411-3 Occurrence Handle1:STN:280:DC%2BD3c7isV2mtg%3D%3D Occurrence Handle10661338

    Article  CAS  PubMed  Google Scholar 

  23. J Garcia-Aguilar E Hernandez de Anda P Sirivongs SH Lee RD Madoff DA Rothenberger (2003) ArticleTitleA pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 298–304 Occurrence Handle12626903

    PubMed  Google Scholar 

  24. V Valentini C Coco N Cellini et al. (1998) ArticleTitlePreoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation Int J Radiat Oncol Biol Phys 40 1067–1075 Occurrence Handle10.1016/S0360-3016(97)00918-8 Occurrence Handle1:STN:280:DyaK1c7pvV2luw%3D%3D Occurrence Handle9539561

    Article  CAS  PubMed  Google Scholar 

  25. CH Crane JM Skibber BW Feig et al. (2003) ArticleTitleResponse to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma Cancer 97 517–524 Occurrence Handle10.1002/cncr.11075 Occurrence Handle12518377

    Article  PubMed  Google Scholar 

  26. JF Bosset G Calais A Daban et al. (2004) ArticleTitlePreoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group Eur J Cancer 40 219–224 Occurrence Handle10.1016/j.ejca.2003.09.032 Occurrence Handle1:STN:280:DC%2BD2c%2FivFentg%3D%3D Occurrence Handle14728936

    Article  CAS  PubMed  Google Scholar 

  27. Bosset JF, Calais G, Mineur L, et al. Preoperative radiation (preoperative RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. Oral presentation. Proceedings of ASCO 2005, Orlando, Florida, May 13–17, 2005;23(16s):247s (abstract 3505).

  28. Gerard JP, Bonnetain F, Conroy T, et al. Preoperative (preop) radiotherapy (RT) +/− 5FU/folinic acid (FA) in T3–4 rectal cancers: results of the FFCD 9203 randomized trial. Oral presentation. Proceedings of ASCO 2005, Orlando, Florida, May 13–17, 2005;23(16s):247s (abstract 3504).

  29. K Bujko MP Nowacki A Nasierowska-Guttmejer et al. (2004) ArticleTitleSphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 15–24 Occurrence Handle10.1016/j.radonc.2003.12.006 Occurrence Handle1:STN:280:DC%2BD2czpsVSmsQ%3D%3D Occurrence Handle15236870

    Article  CAS  PubMed  Google Scholar 

  30. G Freyer N Bossard P Romestaing et al. (2001) ArticleTitleAddition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial J Clin Oncol 19 2433–2438 Occurrence Handle1:CAS:528:DC%2BD3MXjvVelurw%3D Occurrence Handle11331322

    CAS  PubMed  Google Scholar 

  31. JP Gerard O Chapet C Nemoz et al. (2003) ArticleTitlePreoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial J Clin Oncol 21 1119–1124 Occurrence Handle10.1200/JCO.2003.10.045 Occurrence Handle12637479

    Article  PubMed  Google Scholar 

  32. Glynne-Jones R, Sebag-Montefiore D, McDonald A, Falk S, Maughan T. Preliminary phase II SOCRATES study results: Capecitabine combined with oxaliplatin and preoperative radiation in patients with locally advanced rectal cancer. Proceedings of ASCO 2004, New Orleans, Louisiana, June 5–8, 2004;22(14s):263s (abstract 3575).

  33. C Rodel GG Grabenbauer T Papadopoulos W Hohenberger HJ Schmoll R Sauer (2003) ArticleTitlePhase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 3098–3104 Occurrence Handle10.1200/JCO.2003.02.505 Occurrence Handle12915600

    Article  PubMed  Google Scholar 

  34. CG Willett Y Boucher E Tomaso Particledi et al. (2004) ArticleTitleDirect evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 145–147 Occurrence Handle1:CAS:528:DC%2BD2cXoslKmtQ%3D%3D Occurrence Handle14745444

    CAS  PubMed  Google Scholar 

  35. Gray RG, Barnwell J, Hills R, McConkey C, Williams N, Kerr D, for the QUASAR Collaborative Group. QUASAR: A randomized study of adjuvant chemotherapy vs. observation including 3238 colorectal cancer patients. Proceedings of ASCO 2004, New Orleans, Louisiana, June 5–8, 2004 (abstract 3501).

  36. RD James D Donaldson R Gray JM Northover SP Stenning I Taylor InstitutionalAuthorNameAXIS Collaborators (2003) ArticleTitleRandomized clinical trial of adjuvant radiotherapy and 5 fluorouracil infusion in colorectal cancer (AXIS) Br J Surg 90 1200–1212 Occurrence Handle1:STN:280:DC%2BD3srhtVentw%3D%3D Occurrence Handle14515287

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Dr. M. C. Brahimi-Horn for critically reading the manuscript.

Author information

Authors and Affiliations

  1. Department of Radiotherapy, Centre Antoine-Lacassagn, Nice, France

    Cecile Ortholan M.D., Olivier Thomas M.D. & Jean P. Gerard M.D.

  2. Department of Oncology, Centre Antoine-Lacassagne, Nice, France

    Eric Francois M.D.

  3. Department of Surgery, Centre Hospitalier Universitaire de Nice, Nice, France

    Daniel Benchimol Ph.D., M.D.

  4. Department of Surgery, Centre Hospitalier Universitaire de Lyon, Lyon, France

    Jacques Baulieux M.D.

  5. Department of Radiotherapy, Centre Hospitalier Universitaire de Besancon, Besancon, France

    Jean F. Bosset M.D.

  6. Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189, Nice, Cedex 02, France

    Jean P. Gerard M.D.

Authors
  1. Cecile Ortholan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Francois M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olivier Thomas M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Benchimol Ph.D., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jacques Baulieux M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean F. Bosset M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jean P. Gerard M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean P. Gerard M.D..

About this article

Cite this article

Ortholan, C., Francois, E., Thomas, O. et al. Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials. Dis Colon Rectum 49, 302–310 (2006). https://doi.org/10.1007/s10350-005-0263-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-005-0263-x

Key words

Search

Navigation